ArticleOncotarget2016

Impact of suppression of tumorigenicity 14 (ST14)/serine protease 14 (Prss14) expression analysis on the prognosis and management of estrogen receptor negative breast cancer.

Sauryang Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.